| 发明名称 |
TREATMENT OF BLOOD CANCER |
| 摘要 |
<p>Hypoxia activated prodrugs, such as, e.g., TH-281, TH-302, and TH-308, are useful for the treatment of various blood cancers, such as acute leukemias, chronic leukemias, MDS, MF, and multiple myeloma.</p> |
| 申请公布号 |
WO2012006032(A9) |
申请公布日期 |
2012.04.12 |
| 申请号 |
WO2011US42047 |
申请日期 |
2011.06.27 |
| 申请人 |
THRESHOLD PHARMACEUTICALS, INC.;CURD, JOHN;HANDISIDES, DAMIAN;HART, CHARLES;KROLL, STEWART |
发明人 |
CURD, JOHN;HANDISIDES, DAMIAN;HART, CHARLES;KROLL, STEWART |
| 分类号 |
A61K31/4164;A61K31/4168;A61K31/66;A61P35/00;A61P35/02 |
主分类号 |
A61K31/4164 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
